New research has questioned the use of the current classification system for colorectal cancer, which is based on genetic expression profiles, to predict drug responses to FOLFIRI. This question has been raised by a team from the Spanish National Cancer Research Centre (CNIO), formed by members from the Gastrointestinal Cancer Clinical Research Unit and the Structural Computational Biology Group. The study, published this week in the journal emNature Medicine/em, ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment